Ironwood Pharmaceuticals | IRWD - Interest Income


Ironwood Pharmaceuticals reported $778K in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.06M 277K Mar/2026
Agios Pharmaceuticals USD 10.8M 1.62M Mar/2026
Almirall EUR 2.71M 580K Dec/2025
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Amarin USD 3.37M 3.37M Dec/2024
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 80M 7M Jun/2026
Charles River Laboratories USD -0.03 0.27 Jun/2026
Incyte USD 38.12M 4.43M Jun/2026
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Moderna USD 72M 2M Mar/2026
Myriad Genetics USD 300K 0 Mar/2025
Pacira USD 1.93M 365K Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Takeda JPY 24.61B 213.76B Jun/2026
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026